Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.30 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.30 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL845679 | 0.69 | GPR35 (0.50) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL31296983 | 0.64 | GPR35 (0.39) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL12073935 | 0.59 | GPR35 (0.41) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL17112945 | 0.59 | GPR35 (0.41) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL9414145 | 0.58 | GPR35 (0.40) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL31319959 | 0.58 | GPR35 (0.40) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL31377493 | 0.58 | PDPK1 (0.44) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18546448 | 0.58 | GPR35 (0.33) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL178974 | 0.57 | GPR35 (0.40) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL20246987 | 0.57 | ESR1 (0.49) | GPR35HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10403828-B2 | Organic compound, and organic thin film and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-09-03 | — | — | US | disclosed |
| US-9985222-B2 | Organic compound, and organic thin film and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-29 | — | — | US | disclosed |
| US-9985222-B2 | Organic compound, and organic thin film and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-05-29 | — | — | US | disclosed |
| US-20150372241-A1 | ORGANIC COMPOUND, AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
| US-20150372241-A1 | ORGANIC COMPOUND, AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10403828-B2 | Organic compound, and organic thin film and electronic device | OCIAD1, POU2F1, SLCO2A1 | GPR35 4005/4885HDAC3 4697/4885HDAC4 3441/4885 |
| US-20150372241-A1 | ORGANIC COMPOUND, AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | OCIAD1, POU2F1, SLCO2A1 | GPR35 4005/4885HDAC3 4697/4885HDAC4 3441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.